CARDIFF ONCOLOGY, INC. Sales Revenue, Services, Net (Deprecated 2018-01-31)
CARDIFF ONCOLOGY, INC. (CRDF) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $99.94 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2019-05-07
- CARDIFF ONCOLOGY, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2019-03-31 was $99.94K, a 95.64% increase year-over-year.
- CARDIFF ONCOLOGY, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $51.08K.
- CARDIFF ONCOLOGY, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2018 was $127.87K, a 41.87% decline from fiscal 2017.
- CARDIFF ONCOLOGY, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $219.96K, a 155.36% increase from fiscal 2016.
- CARDIFF ONCOLOGY, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $86.14K, a 524.68% increase from fiscal 2015.
- CARDIFF ONCOLOGY, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2015 was $13.79K.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|
| 2019-03-31 | $99.94K 10-Q · filed 2019-05-07 | ||
| 2018-12-31 | $127.87K 10-K · filed 2019-03-06 | ||
| 2018-03-31 | $51.08K 10-Q · filed 2019-05-07 | ||
| 2017-12-31 | $219.96K 10-K · filed 2019-03-06 | $196.11K 10-K · filed 2018-02-26 | |
| 2016-12-31 | $86.14K 10-K · filed 2018-02-26 | ||
| 2015-12-31 | $13.79K 10-K · filed 2017-03-15 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 | ||
| 2013-12-31 | $0.00 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |